DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Proquin XR (Ciprofloxacin Hydrochloride) - Published Studies


Proquin XR Related Published Studies

Well-designed clinical trials related to Proquin XR (Ciprofloxacin)

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). [2014]

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. [2013]

Evaluation of the efficacy and safety of intravenous ciprofloxacin versus meropenem in the treatment of postoperative infection. [2011.10.19]

A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. [2011.08]

Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers. [2011.04]

Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations. [2011.04]

Topical ciprofloxacin is superior to topical saline and systemic antibiotics in the treatment of tympanostomy tube otorrhea in children: the results of a randomized clinical trial. [2010.12]

A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. [2010.12]

Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction. [2010.12]

Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa. [2010.10]

A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. [2010.10]

Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin. [2010.07.15]

Comparative study of pharmacokinetics/ pharmacodynamics of ciprofloxacin between 400 mg intravenously every 8 h and 400 mg intravenously every 12 h in patients with gram negative bacilli bacteremia. [2010.07]

Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial. [2010.05.26]

Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. [2010.04.07]

Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma. [2010.04]

Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. [2010.04]

Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid. [2010.02]

Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis. [2010.01]

Topical ciprofloxacin is superior to topical saline and systemic antibiotics in the treatment of tympanostomy tube otorrhea in children: the results of a randomized clinical trial. [2010]

Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections. [2009.12]

A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. [2009.10]

A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis. [2009.10]

Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. [2009.08.01]

Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates. [2009.07]

A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. [2009.07]

Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline. [2009.06]

Single Dose Azithromycin Versus Ciprofloxacin for Cholera in Children: A Randomized Controlled Trial. [2009.05.20]

A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. [2009.04]

Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin. [2009.02]

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. [2009.01]

Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects. [2009.01]

Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator. [2009]

A Double-blind, Placebo-controlled Trial of Ciprofloxacin Prophylaxis in Patients with Acute Necrotizing Pancreatitis. [2008.12.11]

A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. [2008.12]

Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*. [2008.12]

Effect of ciprofloxacin and ibuprofen on the in vitro metabolism of rosiglitazone and oral pharmacokinetics of rosiglitazone in healthy human volunteers. [2008.10]

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study. [2008.07.30]

Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. [2008.07]

Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC. [2008.07]

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. [2008.05]

Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial. [2008.03]

Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. [2008.02]

A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. [2008.01]

Pharmacokinetics of topically applied ciprofloxacin in equine tears. [2007.11]

Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin. [2007.11]

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. [2007.11]

Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. [2007.10]

Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics. [2007.10]

Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers. [2007.09]

Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers. [2007.06]

A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. [2007.05]

Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. [2007.01.14]

Effect of Five Alive fruit juice on the dissolution and absorption profiles of ciprofloxacin. [2007.01]

Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay. [2007]

Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose. [2006.11]

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. [2006.11]

One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2006.11]

Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. [2006.09]

Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections. [2006.08]

Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients. [2006.06]

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. [2006.06]

Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin. [2006.04.01]

Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa. [2006.04]

Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. [2006.02]

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. [2006.01.01]

Pharmacokinetics of ciprofloxacin XR (1000mg) versus levofloxacin (500mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose. [2006.01]

Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva. [2006]

Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers. [2005.11]

Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. [2005.09.24]

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. [2005.08.15]

Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. [2005.08]

Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study. [2005.08]

Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. [2005.07]

Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. [2005.07]

The role of ciprofloxacin in prolonging polyethylene biliary stent patency: a multicenter, double-blinded effectiveness study. [2005.04]

Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances. [2005.04]

Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. [2005.03]

Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. [2005.02.23]

Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. [2005]

Well-designed clinical trials possibly related to Proquin XR (Ciprofloxacin)

Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. [2014]

Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release. [2013]

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. [2013]

Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. [2013]

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder. [2013]

Use of glass ionomer cement containing antibiotics to seal off infected dentin: a randomized clinical trial. [2013]

Effect of oral N-acetyl cysteine on eradication of Helicobacter pylori in patients with dyspepsia. [2013]

Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection. [2012]

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [2012]

Levetiracetam in the treatment of alcohol dependence: toward the end of the story? [2012]

Analysis of three lamotrigine extended-release clinical trials: comparison of pragmatic ITT and LOCF methodologies. [2012]

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. [2012]

Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials. [2012]

A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. [2012]

Antibiotic prophylaxis in catheter-associated urinary infections. [2012]

Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. [2011.11]

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2011.10.05]

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence. [2011.10]

Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial. [2011.10]

Quetiapine extended release: adjunctive treatment in major depressive disorder. [2011.09.01]

Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study. [2011.09]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017